United States · FDA National Drug Code directory

MEDULTIMA ADVENTURE SUNSCREEN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 84066-109_5368b2b3-fd81-9659-e063-6394a90a0ad3
Product NDC: 84066-109
Form: CREAM
Composition / generic term: Homosalate,Octocrylene, Phenylbenzimidazole Sulfonic Acid, Ethylhexyl Salicylate, Butyl Methoxydibenzoylmethane
Labeler: Guangzhou Tata Biotechnology Co., Ltd.
Marketing category: OTC MONOGRAPH DRUG
Marketing start / end (source format): 20260604
Source listing expiry: 20271231

Source-listed ingredients

OCTOCRYLENE — 7 g/100g
ETHYLHEXYL SALICYLATE — 4 g/100g
PHENYLBENZIMIDAZOLE SULFONIC ACID — 4 g/100g
BUTYL METHOXYDIBENZOYLMETHANE — 3 g/100g
HOMOSALATE — 9 g/100g

These values do not establish equivalence or a dose recommendation.

Packages

50 g in 1 BOTTLE (84066-109-01) · 84066-109-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →